QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time
New Machine Learning Algorithm: QT Imaging Holdings, Inc. has introduced a machine learning-enabled image interpolation algorithm that reduces scan times by approximately 50%, enhancing patient comfort and operational efficiency in medical imaging.
Commitment to Innovation: The company aims to improve health outcomes through safe, affordable, and accessible medical imaging, collaborating with leading institutions to advance cancer detection and treatment technologies.
Trade with 70% Backtested Accuracy
Analyst Views on QTI
About QTI
About the author
QT Imaging to Present at SPIE Medical Imaging Conference
- Technology Showcase: Dr. Bilal Malik, Chief Science Officer of QT Imaging, will present at the SPIE Medical Imaging conference in February 2026, highlighting advancements in its radiation-free breast imaging technology, which is expected to enhance the company's reputation and competitive edge in the medical imaging sector.
- Automated Boundary Extraction: Dr. Malik's presentation will introduce an automated method for accurately defining breast boundaries from reflection data, a critical step that will optimize the image reconstruction process of QT Imaging's Breast Acoustic CT™ scans, thereby improving clinical utility.
- Multi-Step Algorithm Development: The algorithm quickly extracts breast boundaries by detecting primary reflection events and refining them through filtering and interpolation, compensating for missing data near the chest wall, showcasing significant advancements in QT Imaging's technology maturity and clinical applicability.
- Foundation for AI/ML Strategy: This research lays the groundwork for QT Imaging's future AI/ML initiatives, including automated lesion segmentation and clinical decision support tools, aimed at enhancing lesion characterization and streamlining clinical workflows through precise boundary detection and advanced machine learning techniques.
QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time
New Machine Learning Algorithm: QT Imaging Holdings, Inc. has introduced a machine learning-enabled image interpolation algorithm that reduces scan times by approximately 50%, enhancing patient comfort and operational efficiency in medical imaging.
Commitment to Innovation: The company aims to improve health outcomes through safe, affordable, and accessible medical imaging, collaborating with leading institutions to advance cancer detection and treatment technologies.
QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth
Financial Strengthening: QT Imaging Holdings, Inc. has improved its financial position by clearing short-term liabilities and expects significant revenue growth, forecasting $18M in 2025 and $27M in 2026, alongside amendments to its convertible promissory notes that defer payments until March 31, 2026.
Company Overview: QT Imaging is a public medical device company focused on innovative body imaging systems using low-frequency sound waves, aiming to enhance global health outcomes through safe and accessible medical imaging solutions.
QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center
Expansion of Breast Imaging Technology: QT Imaging Holdings, Inc. has partnered with Couri Center for Gynecology and Integrative Women's Health in Peoria, IL, to offer the Breast Acoustic CT™ Scanner, enhancing breast imaging technology focused on patient comfort and safety.
Commitment to Women's Health: Both companies emphasize the importance of providing accurate and high-resolution imaging options, particularly for women with dense breasts or elevated cancer risk, and plan to showcase their technology at an upcoming women's health summit.
QT Imaging Holdings to Attend Radiological Society of North America 2024 Annual Meeting
QT Imaging Holdings Participation: QT Imaging Holdings, Inc. will participate in the Radiological Society of North America 2024 Annual Meeting in Chicago, where Dr. Bilal Malik will present findings on the effectiveness of their QT ultrasound imaging compared to digital breast tomosynthesis for breast cancer screening.
Company Overview: QT Imaging Holdings focuses on developing innovative body imaging systems using low-frequency sound waves, aiming to enhance global health outcomes by providing safe, affordable, and patient-centered diagnostic options.
QT Imaging Announces Third Quarter 2024 Financial Results
Financial Performance: QT Imaging Holdings, Inc. reported $0.9 million in scanner sales revenue for Q3 2024, with a gross margin of 65%, and a net loss of $3.6 million, which included significant interest expenses related to convertible notes.
Strategic Developments: The company successfully completed an engineering and clinical feasibility study, amended its $10 million convertible promissory note, and secured a $2.56 million PIPE investment from insiders to support its commercialization efforts.
QT Imaging to Present at SPIE Medical Imaging Conference
- Technology Showcase: Dr. Bilal Malik, Chief Science Officer of QT Imaging, will present at the SPIE Medical Imaging conference in February 2026, highlighting advancements in its radiation-free breast imaging technology, which is expected to enhance the company's reputation and competitive edge in the medical imaging sector.
- Automated Boundary Extraction: Dr. Malik's presentation will introduce an automated method for accurately defining breast boundaries from reflection data, a critical step that will optimize the image reconstruction process of QT Imaging's Breast Acoustic CT™ scans, thereby improving clinical utility.
- Multi-Step Algorithm Development: The algorithm quickly extracts breast boundaries by detecting primary reflection events and refining them through filtering and interpolation, compensating for missing data near the chest wall, showcasing significant advancements in QT Imaging's technology maturity and clinical applicability.
- Foundation for AI/ML Strategy: This research lays the groundwork for QT Imaging's future AI/ML initiatives, including automated lesion segmentation and clinical decision support tools, aimed at enhancing lesion characterization and streamlining clinical workflows through precise boundary detection and advanced machine learning techniques.
QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time
New Machine Learning Algorithm: QT Imaging Holdings, Inc. has introduced a machine learning-enabled image interpolation algorithm that reduces scan times by approximately 50%, enhancing patient comfort and operational efficiency in medical imaging.
Commitment to Innovation: The company aims to improve health outcomes through safe, affordable, and accessible medical imaging, collaborating with leading institutions to advance cancer detection and treatment technologies.
QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth
Financial Strengthening: QT Imaging Holdings, Inc. has improved its financial position by clearing short-term liabilities and expects significant revenue growth, forecasting $18M in 2025 and $27M in 2026, alongside amendments to its convertible promissory notes that defer payments until March 31, 2026.
Company Overview: QT Imaging is a public medical device company focused on innovative body imaging systems using low-frequency sound waves, aiming to enhance global health outcomes through safe and accessible medical imaging solutions.
QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center
Expansion of Breast Imaging Technology: QT Imaging Holdings, Inc. has partnered with Couri Center for Gynecology and Integrative Women's Health in Peoria, IL, to offer the Breast Acoustic CT™ Scanner, enhancing breast imaging technology focused on patient comfort and safety.
Commitment to Women's Health: Both companies emphasize the importance of providing accurate and high-resolution imaging options, particularly for women with dense breasts or elevated cancer risk, and plan to showcase their technology at an upcoming women's health summit.
QT Imaging Holdings to Attend Radiological Society of North America 2024 Annual Meeting
QT Imaging Holdings Participation: QT Imaging Holdings, Inc. will participate in the Radiological Society of North America 2024 Annual Meeting in Chicago, where Dr. Bilal Malik will present findings on the effectiveness of their QT ultrasound imaging compared to digital breast tomosynthesis for breast cancer screening.
Company Overview: QT Imaging Holdings focuses on developing innovative body imaging systems using low-frequency sound waves, aiming to enhance global health outcomes by providing safe, affordable, and patient-centered diagnostic options.
QT Imaging Announces Third Quarter 2024 Financial Results
Financial Performance: QT Imaging Holdings, Inc. reported $0.9 million in scanner sales revenue for Q3 2024, with a gross margin of 65%, and a net loss of $3.6 million, which included significant interest expenses related to convertible notes.
Strategic Developments: The company successfully completed an engineering and clinical feasibility study, amended its $10 million convertible promissory note, and secured a $2.56 million PIPE investment from insiders to support its commercialization efforts.
